University of Texas at Southwestern — Dallas, Texas

University of Texas at Southwestern is a clinical research site located in Dallas, Texas, United States 75390.

Crixeo Clinical Trials Trust Score: 89/100 (GOOD). This profile has not yet been claimed by the site owner.

University of Texas at Southwestern has participated in 7 clinical trials with 2 currently active.

Therapeutic areas: Craniosynostosis, Relapsed T-Cell Acute Lymphoblastic Leukemia, Relapsed T-Cell Lymphoblastic Lymphoma.

Sponsors: Icahn School of Medicine at Mount Sinai, Therapeutic Advances in Childhood Leukemia Consortium, University of Washington.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Dallas

Browse all research sites in Texas · View every site in Dallas

Sponsor Feasibility Report

Trust Score: 89/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of Texas at Southwestern?

University of Texas at Southwestern has a Crixeo Trust Score of 89/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of Texas at Southwestern conducted?

University of Texas at Southwestern has 7 clinical trials on record, with 2 currently active. Their work covers Craniosynostosis, Relapsed T-Cell Acute Lymphoblastic Leukemia, Relapsed T-Cell Lymphoblastic Lymphoma.

Is University of Texas at Southwestern accredited by Crixeo Clinical Trials?

University of Texas at Southwestern has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about University of Texas at Southwestern?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.